Coated-platelets are higher in amnestic versus nonamnestic patients with mild cognitive impairment

Alzheimer Disease and Associated Disorders

Volumn 21, Issue 3, 2007, Pages 259-261

  Prodan, Calin I ^a,b,d   Ross, Elliott D ^a,b   Vincent, Andrea S ^b   Dale, George L ^c  

^a Veterans Administration   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d NONE   (United States)

Author keywords

Amyloid; MCI; Platelets

Indexed keywords

AMYLOID PRECURSOR PROTEIN; COLLAGEN; THROMBIN;

AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CELL SURFACE; CELL WALL; COGNITIVE DEFECT; CONTROLLED STUDY; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN METABOLISM; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTOPOIESIS;

AGED; AGED, 80 AND OVER; AMNESIA; AMYLOID BETA-PROTEIN PRECURSOR; CASE-CONTROL STUDIES; COGNITION DISORDERS; HUMANS; PLATELET ACTIVATION; PLATELET COUNT;

EID: 34548449798     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31811ec11f     Document Type: Article

References (19)

1. Alberio L, Safa O, Clemetson KJ, et al. Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen and convulxin. Blood. 2000;95:1694-1702.
2. Dale GL, Friese P, Batar P, et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature. 2002;415:175-179.
3. Szasz R, Dale GL. Thrombospondin and fibrinogen bind serotonin- derivatized proteins on COAT platelets. Blood. 2002;100:2827-2831.
4. Szasz R, Dale GL. COAT-platelets. Current Opinion Hematol. 2003;10:351-355.
5. Prodan CI, Szasz R, Vincent AS, et al. Coated-platelets retain amyloid precursor protein on their surface. Platelets. 2006;17:56-60.
6. Prodan CI, Ross ED, Vincent AS, et al. Coated-platelets correlate with disease progression in Alzheimer disease. J Neurol. 2007;254:548-549. DOI: 10.1007/s00415-006-0323-0.
7. Petersen RC, Stevens JC, Ganguli M, et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1133-1142.
8. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240-246.
9. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183-194.
10. Portet F, Ousset PJ, Visser PJ, et al. Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry. 2006;77:714-718.
11. Dale GL. Coated-platelets. An emerging component of the procoagulant response. J Thrombosis Haemostasis. 2005;3:2185-2192.
12. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
13. Petersen RC, Smith GE, Waring SC, et al. Aging, memory, and mild cognitive impairment. Int Psychogeriatr. 1997;9:65-69.
14. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
15. Ritchie K, Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet. 2000;355:225-228.
16. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58:397-405.
17. Masters CL, Beyreuther K. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. Brain. 2006;129:2823-2839.
18. Borroni B, Di Luca M, Padovani A. Predicting Alzheimer dementia in mild cognitive impairment patients. Are biomarkers useful? Eur J Pharmacol. 2006;545:73-80.
19. Tang K, Hynan LS, Baskin F, et al. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease. J Neurol Sci. 2006;240:53-58.